Review Article
A Review of Scrambler Therapy for Chronic Neuropathic Pain
Alexandra M Lesenskyj1, Christina R Maxwell1, Shannon Brown2 and Ricardo A Cruciani1*
1Department of Neurology, Drexel University College of Medicine, Drexel Neurosciences Institute, Philadelphia, USA
2Capital Health Systems, Capital Health Medical Center, Pennington, USA
- *Corresponding Author:
- Ricardo A Cruciani
Department of Neurology, Drexel Neurosciences Institute, Drexel University College of Medicine
Mail Stop-423, 7102-New College Building, PA-19102, Philadelphia, USA
Tel: 215-762-4592
E-mail: Ricardo.Cruciani@drexelmed.edu
Received date: May 19, 2016; Accepted date: August 24, 2016; Published date: August 27, 2016
Citation: Lesenskyj MA, Maxwell RC, Brown S, Cruciani AR (2016) A Review of Scrambler Therapy for Chronic Neuropathic Pain. J Pain Relief 5:260. doi:10.4172/2167-0846.1000260
Copyright: © 2016 Lesenskyj MA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Abstract
Introduction: An increase in accidental death related to prescription opioid abuse prompts the identification of novel strategies to treat chronic pain at a low risk to patients and their communities. Scrambler therapy (ST) has recently emerged as a viable treatment option for patients with neuropathic pain (NP), prompting a systematic review of the literature. Materials and Methods: We conducted a literature search in PubMed, Embase, and other search engines with the key words scrambler therapy, Calmare®, and neuropathic pain. Results: Fifteen studies met the inclusion criteria for the literature review. Each of these studies reported varying degrees of pain reduction when patients were treated via ST. Discussion: ST appears to effectively treat a variety of NP syndromes; however further sham controlled studies are needed to validate this claim.
